Interim results of a phase II single arm trial combining afatinib with cetuximab in patients with EGFRex20ins positive NSCLC.

Bianca van Veggel, Anthonie J. van der Wekken, Marthe Paats, Sayed MS Hashemi, Lizza Hendriks, Karolina Sikorska, Daan van den Broek, Kim Monkhorst, Egbert F. Smit, Joop De Langen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

9112

Original languageEnglish
JournalJournal of Clinical Oncology
Volume39
Issue number15_suppl
DOIs
Publication statusPublished - 2021

Cite this